Metadata Search
Angelini Pharma
Page 1 of 16 results
Sort by: relevance publication year Download as CSV

5-HT 2A -mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT 2A to mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis

Journal Article published May 2018 in Neuropharmacology volume 133 on pages 429 to 439

Research funded by Università degli Studi di Genova | Angelini Pharma

Authors: Guendalina Olivero, Massimo Grilli, Matteo Vergassola, Tommaso Bonfiglio, Cristina Padolecchia, Beatrice Garrone, Francesco Paolo Di Giorgio, Serena Tongiani, Cesare Usai, Mario Marchi, Anna Pittaluga

Increased rate of penicillin non-susceptible strains of N. meningitidis in Naples, Italy

Journal Article published 20 Jul 2017 in Journal of Chemotherapy volume 29 issue 6 on pages 389 to 390

Research funded by Pfizer | Novartis | Merck | Angelini Pharma | Thermofisher | Astellas Pharma US

Authors: Giovanni Di Caprio, Novella Carannante, Mariano Bernardo, Susanna Cuccurullo, Carlo Pallotto, Carlo Tascini

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)

Journal Article published 28 Nov 2016 in European Journal of Clinical Microbiology & Infectious Diseases volume 36 issue 4 on pages 677 to 680

Research funded by Angelini Pharma

Authors: D. Knafl, S. Tobudic, S. C. Cheng, D. R. Bellamy, F. Thalhammer

New Antibiotics for Pneumonia

Journal Article published Dec 2018 in Clinics in Chest Medicine volume 39 issue 4 on pages 853 to 869

Research funded by Cidara Therapeutics | Mount Sylvia Diatomite | Pfizer | Shionogi | The Medicine Company | Astellas Pharma | Menarini | Achaogen | VenatoRx | Basilea | Gilead Sciences | Tetraphase | Angelini Pharma | Roche | AstraZeneca | Vifor | Paratek | Bayer

Authors: Matteo Bassetti, Elda Righi, Alessandro Russo, Alessia Carnelutti

Health care costs of influenza-related episodes in high income countries: A systematic review

Journal Article published 7 Sep 2018 in PLOS ONE volume 13 issue 9 on page e0202787

Research funded by Angelini Pharma

Authors: Carlo Federici, Marianna Cavazza, Francesco Costa, Claudio Jommi

Editors: Pieter T. de Boer

Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters

Journal Article published 1 Aug 2017 in International Journal of Bipolar Disorders volume 5 issue 1

Research funded by the RTG “gk emotions” (1256/2) | Canadian Institutes of Health Research (64410) | Bruce J. Anderson Foundation | Deutsche Forschungsgemeinschaft, European Commission (FP7) | German Excellence Initiative to the Graduate School of Life Sciences | American Foundation for Suicide Prevention | Bundesministerium für Bildung und Forschung | McLean Private Donors Research Fund | Aretæus Foundation | Fondo Europeo de Desarrollo Regional, Unión Europea | Spanish Ministry of Economy and Competitiveness (00912) | Angelini Pharma | CIBERSAM and the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement (2014-SGR-398) | Instituto de Salud Carlos III, Subdirección General de Evaluación y Fomento de la Investigación

Authors: Leonardo Tondo, Maria Abramowicz, Martin Alda, Michael Bauer, Alberto Bocchetta, Lorenza Bolzani, Cynthia V. Calkin, Caterina Chillotti, Diego Hidalgo-Mazzei, Mirko Manchia, Bruno Müller-Oerlinghausen, Andrea Murru, Giulio Perugi, Marco Pinna, Giuseppe Quaranta, Daniela Reginaldi, Andreas Reif, Philipp Ritter, Janusz K. Rybakowski, David Saiger, Gabriele Sani, Valerio Selle, Thomas Stamm, Gustavo H. Vázquez, Julia Veeh, Eduard Vieta, Ross J. Baldessarini

Risk of Acute Cerebrovascular and Cardiovascular Events Among Users of Acetaminophen or an Acetaminophen-Codeine Combination in a Cohort of Patients with Osteoarthritis: A Nested Case-Control Study

Journal Article published Oct 2015 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy volume 35 issue 10 on pages 899 to 909

Research funded by Angelini Pharma

Authors: Giuseppe Roberto, Monica Simonetti, Carlo Piccinni, Pier Lora Aprile, Iacopo Cricelli, Andrea Fanelli, Claudio Cricelli, Francesco Lapi

Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

Journal Article published 6 Jun 2018 in European Journal of Clinical Microbiology & Infectious Diseases volume 37 issue 9 on pages 1611 to 1618

Research funded by Angelini Pharma

Authors: Tom Stargardt, Christian Eckmann, Emilio Bouza, Gian Maria Rossolini, Paolo Antonio Grossi

The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis

Journal Article published 29 Aug 2018 in Ocular Immunology and Inflammation on pages 1 to 11

Research funded by National Institute for Health Research | Research to Prevent Blindness | Angelini Pharma | AbbVie | Allergan | Department of Biotechnology, Government of West Bengal

Authors: Rupesh Agrawal, Dinesh Visva Gunasekeran, Aniruddha Agarwal, Ester Carreño, Kanika Aggarwal, Bhaskar Gupta, Dhananjay Raje, Somasheila I. Murthy, Mark Westcott, Soon Phaik Chee, Peter McCluskey, Ho Su Ling, Stephen Teoh, Luca Cimino, Jyotirmay Biswas, Shishir Narain, Manisha Agarwal, Padmamalini Mahendradas, Moncef Khairallah, Nicholas Jones, Ilknur Tugal-Tutkun, Kalpana Babu, Soumayava Basu, Richard Lee, Hassan Al-Dhibi, Bahram Bodaghi, Alessandro Invernizzi, Debra A. Goldstein, Carl P. Herbort, Talin Barisani-Asenbauer, Julio J. González-López, Sofia Androudi, Reema Bansal, Bruttendu Moharana, Sarakshi Mahajan, Simona Esposti, Anastasia Tasiopoulou, Sengal Nadarajah, Mamta Agarwal, Sharanya Abraham, Ruchi Vala, Joanne Lord, Ramandeep Singh, Aman Sharma, Kusum Sharma, Manfred Zierhut, Onn Min Kon, John Kempen, Emmett T. Cunningham, Andres Rousselot, Quan Dong Nguyen, Carlos Pavesio, Vishali Gupta

Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia. A five-year follow-up

Journal Article published Feb 2019 in European Psychiatry volume 56 on pages 60 to 68

Research funded by Sunovion | Madrid Regional Government (S2010/ BMD-2422 AGES, B2017/BMD-3740 AGES CM 2-CM) | Ferrer | Pfizer | Farmindustria | Bristol-Myers Squibb | Instituto de Salud Carlos III, Fondo de Investigación Sanitaria (FIS) | Sanofi | Otsuka | Forest Research Institute | Dainippon Sumitomo Pharma | Juste | Allergan | Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) | Lundbeck | JanssenCilag | Servier | Spanish Ministry of Science and Innovation (CIBERSAM) | Stanley Medical Research Institute | Shire | Seventh European Framework Programme (ENBREC) | Glaxo-Smith-Kline | Angelini Pharma | Roche | Janssen | AstraZeneca | Gedeon Richter | Brain and Behaviour Foundation | AB-Biotics | Takeda Pharmaceuticals U.S.A.

Authors: Estela Jiménez-López, Eva María Sánchez-Morla, Ana López-Villarreal, Ana Isabel Aparicio, Vicente Martínez-Vizcaíno, Eduard Vieta, Roberto Rodriguez-Jimenez, José Luis Santos